Which cervical and endometrial cancer patients will benefit most from intensity-modulated proton therapy?
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 27452411.
- Also identified by DOI 10.1016/j.radonc.2016.06.016.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In this dosimetric comparison study it was shown that IMPT with robust planning reduces dose to surrounding organs in cervical and endometrial cancer treatment compared with IMRT. Especially for the para-aortic region, clinically relevant dose reductions were obtained for kidneys, spinal cord and bowel, justifying the use of proton therapy for this indication.
Medical subject headings
- Endometrial Neoplasms
- Proton Therapy
- Radiotherapy, Intensity-Modulated
- Uterine Cervical Neoplasms